EPAS1 and Insulin resistance: When mice on high fat diet were treated with HIF-2α agonist FG-4592 (prolyl hydroxylase inhibitor), impaired glucose tolerance and insulin resistance was alleviated with no effect on fasting glucose or body weight and significantly reduced serum IL-1β and IL-18 [113].